Ultrasound‐guided percutaneous metal‐organic frameworks based codelivery system of doxorubicin/acetazolamide for hepatocellular carcinoma therapy

Ultrasound‐guided percutaneous metal‐organic frameworks based codelivery system of doxorubicin/acetazolamide for hepatocellular carcinoma therapy

Bibliographic Details
Main Authors:	Ziwei Jing, Xiaohui Wang, Na Li, Zhi Sun, Dingding Zhang, Lin Zhou, Fanxiang Yin, Qingquan Jia, Mengli Wang, Yaojuan Chu, Shuzhang Du, Yaping He, Qiuzheng Du, Xiaojian Zhang
Format:	Article
Language:	English
Published:	Wiley 2021-10-01
Series:	Clinical and Translational Medicine
Online Access:	https://doi.org/10.1002/ctm2.600

Similar Items

Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
by: Yi Zhang, et al.
Published: (2018-06-01)

Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
by: Ke Li, et al.
Published: (2019-12-01)

Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
by: Jin X, et al.
Published: (2016-09-01)

A Modular Coassembly Approach to All-In-One Multifunctional Nanoplatform for Synergistic Codelivery of Doxorubicin and Curcumin
by: Muyang Yang, et al.
Published: (2018-03-01)

Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin
by: Zou S, et al.
Published: (2012-07-01)

Smart Magnetic Nanocarriers for Codelivery of Nitric Oxide and Doxorubicin for Enhanced Apoptosis in Cancer Cells
by: Bijaideep Dutta, et al.
Published: (2023-11-01)

Dual-Functional Peptide Driven Liposome Codelivery System for Efficient Treatment of Doxorubicin-Resistant Breast Cancer
by: Ahmed KS, et al.
Published: (2021-07-01)

Redox-responsive mesoporous silica nanoparticles : a physiologically sensitive codelivery vehicle for siRNA and doxorubicin
by: Ma, Xing, et al.
Published: (2015)

Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer
by: Wang BL, et al.
Published: (2013-09-01)

Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment
by: Wang D, et al.
Published: (2017-12-01)

Discovery of quality markers for Mailuoshutong Pill based on “spider web” mode of “Content-Pharmacokinetics-Pharmacology” network
by: Mengli Wang, et al.
Published: (2022-12-01)

Enzyme-Enhanced Codelivery of Doxorubicin and Bcl-2 Inhibitor by Electrospun Nanofibers for Synergistic Inhibition of Prostate Cancer Recurrence
by: Zheng Liu, et al.
Published: (2022-10-01)

Self-Assembling pH-Responsive Nanoparticle Platform Based on Pectin–Doxorubicin Conjugates for Codelivery of Anticancer Drugs
by: Yinghua Tao, et al.
Published: (2021-04-01)

Aptamer-Mediated Codelivery of Doxorubicin and NF-κB Decoy Enhances Chemosensitivity of Pancreatic Tumor Cells
by: David Porciani, et al.
Published: (2015-01-01)

Surface PEGylated Cancer Cell Membrane-Coated Nanoparticles for Codelivery of Curcumin and Doxorubicin for the Treatment of Multidrug Resistant Esophageal Carcinoma
by: Yi Gao, et al.
Published: (2021-07-01)

Codelivery of doxorubicin and triptolide with reduction-sensitive lipid–polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment
by: Wu B, et al.
Published: (2017-03-01)

A nanoselenium-coating biomimetic cytomembrane nanoplatform for mitochondrial targeted chemotherapy- and chemodynamic therapy through manganese and doxorubicin codelivery
by: Jianmin Xiao, et al.
Published: (2021-07-01)

Acetazolamide for Partial Seizures
by: J Gordon Millichap
Published: (1989-01-01)

Growth Suppression with Acetazolamide
by: J Gordon Millichap
Published: (1997-01-01)

Acetazolamide in Hydrocephalus Management
by: J Gordon Millichap
Published: (1995-02-01)

Acetazolamide in Vestibulocerebellar Syndrome
by: J Gordon Millichap
Published: (1991-05-01)

Nano lipidic carriers for codelivery of sorafenib and ganoderic acid for enhanced synergistic antitumor efficacy against hepatocellular carcinoma
by: Bin Wang, et al.
Published: (2021-08-01)

Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy
by: Ting Zhao, et al.
Published: (2022-04-01)

Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance
by: Haghiralsadat F, et al.
Published: (2018-07-01)

Acetazolamide Monotherapy for Myoclonic Epilepsy
by: J Gordon Millichap
Published: (1990-11-01)

Acetazolamide in Hypokalemic Periodic Paralysis
by: J Gordon Millichap
Published: (2000-09-01)

Rare toxicity of diamox (acetazolamide)
by: Bhatnagar N
Published: (1983-01-01)

Stroke Mimic Caused by Acetazolamide
by: Tiago Manuel Mendes
Published: (2018-02-01)

Acetazolamide in prevention of altitude disease
by: Paweł Choroszewicz, et al.
Published: (2020-05-01)

Targeted codelivery of nitric oxide and hydrogen sulfide for enhanced antithrombosis efficacy
by: Weiliang Deng, et al.
Published: (2025-06-01)

Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers
by: Girish Kumar, et al.
Published: (2023-03-01)

Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier
by: Li JM, et al.
Published: (2015-04-01)

Combination therapy based on nano codelivery for overcoming cancer drug resistance
by: Hairui Wang, et al.
Published: (2020-06-01)

Familial Paroxysmal Ataxia: Acetazolamide Therapy
by: J Gordon Millichap
Published: (1992-05-01)

Role of diamox (acetazolamide) in cataract surgery
by: Maria D, et al.
Published: (1970-01-01)

Acetazolamide: Old drug, new evidence?
by: Arif Ali Shukralla, et al.
Published: (2022-09-01)

Role Of Acetazolamide In The Treatment Of Partial Epilepsy
by: Iype T, et al.
Published: (2000-01-01)

Erythema multiforme secondary to acetazolamide (Diamox)
by: Nayak A, et al.
Published: (1981-01-01)

Acetazolamide for the treatment of acute mountain sickness
by: Luciano Tapia, et al.
Published: (2019-12-01)

UHPLC-HRMS-based metabolomic and lipidomic characterization of glioma cells in response to anlotinib
by: Yingying Shi, et al.
Published: (2023-05-01)